Yield Growth Corp. (CSE:BOSS) has launched its campaign on the Investing News Network’s Cannabis channel.

Yield Growth is a cannabis asset growth corporation with assets in media, technology and products. The company primarily acquires, develops, markets and sells wellness and cosmetic products through their wholly-owned subsidiary Urban Juve Provisions Inc. under the brand Urban Juve. Their products are sold directly to consumers through their e-commerce platform and will be available in retail stores across Canada. Yield Growth Corp. also licenses its products, intellectual property (IP) and technology to companies around the world.


To date, Yield Growth Corp. has developed 50 hemp- and cannabis-based products to sell under their Urban Juve brand, including anti-aging serums, bath salts, pain patches and antihistamines and more. Two of the 50 products that have been developed are available for purchase on the company’s e-commerce platform and the remainder of their products will be rolled out in four phases.

Yield Growth Corp.’s second subsidiary, Thrive Activations Inc., was created with the intent to provide technology solutions to businesses looking for a competitive advantage. To meet this goal, Thrive offers technology advisory and marketing services, among others, to businesses in Vancouver, British Columbia.

Yield Growth’s company highlights include the following:

  • Operating under a B2C and B2B business model.
  • Global cannabis market expected to surpass $31 billion by 2021.
  • Global wellness market reached $4.2 trillion in 2017.
  • Developed 50 unique hemp- and cannabis-based wellness and cosmetic products.
  • 26 Health Canada product registrations have been completed to date.
  • 11 US patent applications filed to date.
  • CROP is a strategic partner that provides the company with exposure in Italy and the US.
  • Led by an experienced management team that has worked with big-name retail brands from across the globe.

Click here to see the educational profile for Yield Growth Corp. (CSE:BOSS) and to request an investor presentation.

Fundraising, Subscription by Directors and Love Hemp Q1 Trading Update

World High Life Plc (“World High Life” or the “Company”) (AQSE:LIFE) (OTCQB:WRHLF) announces that it has raised £566,206 via the issue of 56,620,600 ordinary shares of 1 pence each in the Company (“Ordinary Shares”; the “Subscription Shares”) at a subscription price of 1.0p per share. The proceeds of the Subscription Shares will be used by the Company for general working capital purposes

Keep reading... Show less

Global Wellness Strategies Inc. (formerly Redfund Capital Corp.) (CSE: LOAN) (FSE: O3X4) (OTCQB: PNNRD) (“Global” or the “Company”) announces it has signed a binding letter of intent (“BLOI”) on January 22, 2021 with EntheoTech Bioscience Inc. (“ET”) a wellness psilocybin leader based in Kelowna, British Columbia and will have the option to earn up to a 19.9% interest in ET.

EntheoTech is a Canadian bioscience company focused on the research and development of products, and protocols to promote brain health, performance optimization, and global wellness, using psychoactive substances such as psilocybin, medicinal mushrooms, and other natural products.

Keep reading... Show less

The new dispensary brings expanded access for patients along Florida’s Atlantic Coast

Trulieve Cannabis Corp. (CSE: TRUL)  (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 78th nationwide. The new 4,600 sq. ft. location marks the Company’s first in the city of Sebastian and second in Indian River county expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC) will release its financial results for the third quarter fiscal 2021 ended December 31, 2020 before financial markets open on February 9, 2021.

Keep reading... Show less

NYSE | TSX: ACB

Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the closing of its previously announced bought deal public offering (the “Offering”) of units of the Company (the “Units”) for total gross proceeds of US$137,940,000 . The Company sold 13,200,000 Units at a price of US$10.45 per Unit, including 1,200,000 Units sold pursuant to the exercise in full of the underwriters’ over-allotment option.

Keep reading... Show less